Pyrazinamide

Welcome to Dwaey, specifically on Pyrazinamide page.
This medicine contains important and useful components, as it consists of
Pyrazinamide is available in the market in concentration.

Generic Name of Pyrazinamide - Learn More

Pyrazinamide

Pyrazinamide Precaution - What You Need to Know

Before starting treatment with Pyrazinamide, it is essential for patients to consult with their healthcare provider to ensure its appropriateness for their condition. Several important precautions should be considered:

- Liver Disease: Pyrazinamide can cause liver damage, and its use should be avoided or closely monitored in individuals with pre-existing liver conditions, such as cirrhosis or active hepatitis.
- Alcohol Use: Alcohol consumption should be limited or avoided while on Pyrazinamide due to the increased risk of liver toxicity.
- Pregnancy: Pyrazinamide is classified as a Category C medication during pregnancy, which means it should be used only if the potential benefits outweigh the risks. It is typically prescribed in combination with other anti-tubercular drugs for treating tuberculosis (TB) during pregnancy, but the healthcare provider must carefully weigh the risks.
- Renal Impairment: Patients with kidney problems should use Pyrazinamide cautiously, as it is primarily excreted through the kidneys. Dosage adjustments may be necessary.
- Gout and Hyperuricemia: Pyrazinamide can increase uric acid levels in the blood, potentially leading to gout or worsening existing gout symptoms. Patients with a history of gout should be monitored closely.
- Diabetes: Individuals with diabetes may be at an increased risk of liver complications and should be monitored regularly during treatment.

Patients should follow their healthcare provider's instructions carefully to reduce the risk of side effects and ensure optimal treatment.

Pyrazinamide Indication - Uses and Benefits

Pyrazinamide is an essential part of the treatment regimen for tuberculosis (TB). Its primary indications include:

- Tuberculosis (TB): Pyrazinamide is used as a first-line treatment for both active pulmonary tuberculosis and extrapulmonary tuberculosis. It is usually administered as part of a combination therapy alongside other anti-tubercular medications, such as rifampin, isoniazid, and ethambutol. Pyrazinamide helps to kill the Mycobacterium tuberculosis bacteria and is particularly effective in the initial phase of treatment.
- Mycobacterium avium Complex (MAC) Infection: Pyrazinamide may also be used to treat infections caused by Mycobacterium avium in immunocompromised individuals, such as those with HIV/AIDS.

As part of a combination regimen, Pyrazinamide contributes to a more effective and quicker resolution of tuberculosis, preventing the development of drug resistance when used properly. It is critical that patients adhere to their prescribed treatment plan and follow up with their healthcare provider.

Pyrazinamide Contraindications - Important Warnings

Certain conditions and situations may contraindicate the use of Pyrazinamide due to the potential for severe adverse effects:

- Active Liver Disease: Pyrazinamide is contraindicated in patients with active liver disease, such as acute hepatitis or cirrhosis, as it can cause significant liver toxicity and worsen the condition.
- Severe Renal Impairment: Patients with severe renal impairment or end-stage kidney disease should avoid using Pyrazinamide unless absolutely necessary, as the drug is primarily eliminated through the kidneys and may accumulate in the body.
- Gout and Hyperuricemia: Pyrazinamide is contraindicated in individuals with a history of gout or hyperuricemia unless the benefits clearly outweigh the risks. The drug can elevate uric acid levels, potentially precipitating a gout attack.
- Pregnancy (first trimester): Although Pyrazinamide is used during pregnancy when necessary, it is typically avoided during the first trimester due to the potential risks to the developing fetus. It should only be used in pregnancy if the benefits outweigh the risks and after consulting with a healthcare provider.

As always, patients should discuss any underlying conditions with their healthcare provider before starting treatment with Pyrazinamide.

Pyrazinamide Side Effects - What to Expect

Pyrazinamide is generally well-tolerated when used in combination with other anti-tubercular drugs, but it may cause several side effects. Common side effects include:

- Liver Toxicity: One of the most significant risks associated with Pyrazinamide is liver damage. Symptoms of liver issues include jaundice (yellowing of the skin or eyes), dark urine, pale stools, and persistent fatigue.
- Gastrointestinal Distress: Nausea, vomiting, anorexia (loss of appetite), and abdominal pain are common side effects.
- Joint Pain (Arthralgia): Pyrazinamide can lead to joint pain and swelling, which is related to its effect on uric acid levels, potentially triggering a gout attack.
- Rash: Some patients may develop a rash, which could be an allergic reaction. Severe rashes should be reported to a healthcare provider.
- Fever: A low-grade fever may occur in some patients.

Severe adverse effects, although rare, require immediate medical attention. These include:

- Severe Liver Injury: Symptoms such as severe abdominal pain, nausea, and jaundice require prompt medical intervention.
- Anemia: Blood-related complications such as anemia, characterized by fatigue, weakness, and pallor, should be evaluated by a healthcare provider.
- Severe Allergic Reactions: Signs of an allergic reaction include swelling of the face, lips, tongue, or throat, and difficulty breathing.

Patients should report any persistent or severe side effects to their healthcare provider.

Pyrazinamide Pregnancy Category ID - Safety Information

3

Pyrazinamide Mode of Action - How It Works

Pyrazinamide works by inhibiting the growth of Mycobacterium tuberculosis, the bacterium responsible for tuberculosis. It is bactericidal at acidic pH, which is the environment found within phagosomes in macrophages that contain the bacteria. Pyrazinamide is converted to its active form, pyrazinoic acid, inside the body. This active metabolite inhibits the fatty acid synthase enzyme, which is essential for mycobacterial cell wall synthesis. In addition, pyrazinoic acid disrupts the bacterium’s ability to maintain its cellular integrity. As a result, Mycobacterium tuberculosis is effectively killed, particularly in the initial stages of infection and in macrophages, which are critical for eliminating the infection. This action is why Pyrazinamide is an important component of combination therapy for TB treatment.

Pyrazinamide Drug Interactions - What to Avoid

Pyrazinamide may interact with several other medications, affecting their efficacy or increasing the risk of side effects. Key interactions include:

- Rifampin and Isoniazid: These are other common drugs used to treat tuberculosis. Pyrazinamide is often used in combination with rifampin and isoniazid. However, their combined use can increase the risk of liver toxicity, so liver function should be monitored closely.
- Allopurinol: Since Pyrazinamide can increase uric acid levels, combining it with allopurinol, a medication used to treat gout, can increase the risk of side effects such as rash, liver toxicity, and fever.
- Phenytoin: Pyrazinamide may interfere with the metabolism of phenytoin, a drug used to control seizures, potentially leading to decreased seizure control. Regular monitoring of phenytoin levels is recommended if both drugs are prescribed.
- Oral Anticoagulants: Caution is recommended when using oral anticoagulants (e.g., warfarin) alongside Pyrazinamide, as the drug can affect blood clotting mechanisms, requiring careful monitoring of INR (International Normalized Ratio).
- Alcohol: Alcohol can exacerbate Pyrazinamide's liver toxicity. Concurrent use should be avoided to prevent liver damage.

It is important to inform healthcare providers about all medications, including over-the-counter drugs, vitamins, and herbal supplements, to avoid harmful interactions.

Pyrazinamide Adult Dose - Recommended Dosage

The recommended dose of Pyrazinamide for adults typically depends on the patient’s weight and the specific treatment regimen. Standard dosing for pulmonary tuberculosis in adults is:

- Initial Phase: The usual dose is 25 mg/kg of body weight, taken once daily, for the first two months as part of the combination therapy.
- Continuation Phase: After the initial two months, Pyrazinamide is often discontinued, but it may be continued as part of a modified regimen based on the patient's condition and the healthcare provider’s judgment.

The maximum dose should not exceed 2 grams per day.

It is essential that the prescribed dose is followed precisely, and patients should consult their healthcare provider for the best dosing schedule based on their specific needs.

Pyrazinamide Child Dose - Dosage for Children

Pyrazinamide is commonly used in pediatric patients as part of tuberculosis treatment regimens. For children, the usual dose is:

- Infants and Children under 30 kg: 25 mg/kg of body weight, administered once daily.
- Children over 30 kg: The dose is typically 750 mg to 1 gram per day.

The treatment duration is similar to that for adults, with Pyrazinamide used primarily during the initial phase of tuberculosis therapy. However, pediatric dosing should always be determined by a healthcare provider based on the child’s age, weight, and health status.

It is critical for caregivers to follow healthcare provider instructions precisely and ensure that children are monitored for any adverse effects during treatment.

Pyrazinamide Renal Dose - Dosage for Kidney Conditions

Pyrazinamide is primarily excreted via the kidneys, so dose adjustments may be necessary in patients with renal impairment. For individuals with moderate renal insufficiency (creatinine clearance <50 mL/min), the dose of Pyrazinamide may need to be reduced, and renal function should be closely monitored. For patients with severe renal impairment or those on dialysis, the use of Pyrazinamide is generally avoided unless no other treatment options are available. In such cases, the healthcare provider should determine the appropriate dosing or consider alternative therapies.